Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study) - Mortier, L; Bertrand, N; Basset-Seguin, N (Journal of Clinical Oncolog, 2018)
et al.